South Africa Drug Device Combination Products Market Size & Outlook
Related Markets
South Africa drug device combination products market highlights
- The South Africa drug device combination products market generated a revenue of USD 977.1 million in 2023 and is expected to reach USD 1,620.5 million by 2030.
- The South Africa market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, transdermal patches was the largest revenue generating product in 2023.
- Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.
Drug device combination products market data book summary
| Market revenue in 2023 | USD 977.1 million |
| Market revenue in 2030 | USD 1,620.5 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Transdermal patches |
| Fastest growing segment | Drug Eluting Stents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
| Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.7% of the global drug device combination products market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa drug device combination products market is projected to lead the regional market in terms of revenue in 2030.
- Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 543.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Device Combination Products Market Scope
Drug Device Combination Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| W L Gore & Associates | View profile | 5001-10000 | Newark, Delaware, United States, North America | https://www.gore-tex.com/en_uk |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Teleflex Inc | View profile | 14500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | https://www.teleflex.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
South Africa drug device combination products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the South Africa drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as rising healthcare spending, growing prevalence of cancer, and increasing number of minimally invasive surgeries are expected to drive market growth in South Africa during the forecast period. Furthermore, the government in the country has been adopting measures to improve the state of healthcare facilities.
The government allocates 11% of the resources to the healthcare sector from the total government expenditure. There are more than 200 private hospitals and over 400 public hospitals in the country. About 40% of the total healthcare expenditure is carried out by the government. Due to this, the private sector is under pressure to provide appropriate services to most citizens.
This is expected to drive the market in the near future. The rising prevalence of chronic diseases like cancer & diabetes in the country may offer lucrative opportunities for the market. For instance, according to the International Diabetes Federation, diabetes prevalence reached 11.3% and accounted for 96,000 deaths in South Africa in 2021.
Reasons to subscribe to South Africa drug device combination products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa drug device combination products market databook
-
Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into South Africa drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa drug device combination products market size, by drug eluting stents, 2018-2030 (US$M)
South Africa Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
